Yüklüyor......
Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study
AIMS: Regulatory review time has been associated with post-market medication safety issues in the United States. Our objective was to evaluate whether regulatory review time and near deadline approval are associated with post-market safety events (PMSEs) for novel medicines approved by the European...
Kaydedildi:
| Yayımlandı: | Br J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4594708/ https://ncbi.nlm.nih.gov/pubmed/25808713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12643 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|